MediciNova Announces Closing of Underwritten Public Offering of Common Stock

MediciNova Announces Closing of Underwritten Public Offering of Common Stock


MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , announced today the closing of the previously announced underwritten public offering of 4,419,890 shares of its common stock at a price to the public of $9.05 per share. The gross proceeds to MediciNova from this offering were approximately $40.0 million, before deducting the underwriting discount and other estimated offering expenses.



from Biotech News